Mount Vernon Associates Inc. MD Has $219,000 Stock Position in The Procter & Gamble Company (NYSE:PG)

Mount Vernon Associates Inc. MD reduced its stake in The Procter & Gamble Company (NYSE:PG) by 18.4% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,328 shares of the company’s stock after selling 300 shares during the quarter. Mount Vernon Associates Inc. MD’s holdings in Procter & Gamble were worth $219,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Alera Investment Advisors LLC raised its stake in shares of Procter & Gamble by 1.2% during the 1st quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock valued at $812,000 after buying an additional 60 shares during the last quarter. Fiduciary Alliance LLC raised its stake in shares of Procter & Gamble by 2.8% during the 2nd quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company’s stock valued at $371,000 after buying an additional 61 shares during the last quarter. Demars Financial Group LLC raised its stake in shares of Procter & Gamble by 4.4% during the 4th quarter. Demars Financial Group LLC now owns 1,497 shares of the company’s stock valued at $219,000 after buying an additional 63 shares during the last quarter. LCM Capital Management Inc raised its stake in shares of Procter & Gamble by 1.1% during the 1st quarter. LCM Capital Management Inc now owns 5,701 shares of the company’s stock valued at $925,000 after buying an additional 63 shares during the last quarter. Finally, Home Federal Bank of Tennessee raised its stake in shares of Procter & Gamble by 0.3% during the 2nd quarter. Home Federal Bank of Tennessee now owns 23,318 shares of the company’s stock valued at $3,846,000 after buying an additional 63 shares during the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Stock Down 0.0 %

NYSE:PG traded down $0.03 during trading hours on Friday, hitting $167.89. The company’s stock had a trading volume of 5,640,925 shares, compared to its average volume of 7,681,546. The stock has a market capitalization of $396.24 billion, a P/E ratio of 27.43, a price-to-earnings-growth ratio of 3.66 and a beta of 0.41. The stock has a fifty day moving average of $166.99 and a 200-day moving average of $163.26. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $171.72.

Procter & Gamble (NYSE:PG) last posted its earnings results on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, beating the consensus estimate of $1.37 by $0.03. The firm had revenue of $20.53 billion for the quarter, compared to analyst estimates of $20.69 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. Procter & Gamble’s revenue for the quarter was down .1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.37 earnings per share. On average, equities analysts forecast that The Procter & Gamble Company will post 6.97 earnings per share for the current year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were paid a $1.0065 dividend. The ex-dividend date of this dividend was Friday, July 19th. This represents a $4.03 annualized dividend and a yield of 2.40%. Procter & Gamble’s dividend payout ratio is presently 65.85%.

Analyst Ratings Changes

A number of research firms have weighed in on PG. Stifel Nicolaus lifted their price objective on Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research note on Monday, July 22nd. Barclays cut their price target on Procter & Gamble from $174.00 to $163.00 and set an “overweight” rating for the company in a research note on Thursday, August 1st. Evercore ISI lifted their price target on Procter & Gamble from $177.00 to $183.00 and gave the company an “outperform” rating in a research note on Thursday, July 18th. Deutsche Bank Aktiengesellschaft boosted their price objective on Procter & Gamble from $171.00 to $176.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Finally, Argus boosted their target price on Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a report on Thursday, April 25th. Nine analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average target price of $173.95.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the transaction, the insider now owns 11,537 shares in the company, valued at $1,902,451.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the sale, the insider now owns 11,537 shares in the company, valued at $1,902,451.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Sundar G. Raman sold 31,924 shares of the stock in a transaction dated Monday, May 20th. The stock was sold at an average price of $166.95, for a total transaction of $5,329,711.80. Following the sale, the chief executive officer now owns 19,042 shares of the company’s stock, valued at approximately $3,179,061.90. The disclosure for this sale can be found here. Insiders sold 116,313 shares of company stock worth $19,703,643 over the last 90 days. Corporate insiders own 0.17% of the company’s stock.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.